Akca, ZekiMutlu, HasanErden, AbdulsametBuyukcelik, AbdullahCihan, Yasemin BenderliGoksu, Sema SezginAslan, TuncaySezer, Emel YamanInal, Ali2023-02-212023-02-212014-01-0110.7314/APJCP.2014.15.15.6025https://hdl.handle.net/11443/2363http://dx.doi.org/10.7314/APJCP.2014.15.15.6025Background: Because of the relative rarity of biliary tract cancers (BTCs), defining long term survival results is difficult. In the present study, we aimed to evaluate the survival of a series of cases in Turkey. Materials and Methods: A totally of 47 patients with billiary tract cancer from Mersin Goverment Hospital, Acibadem Kayseri Hospital and Kayseri Training and Research Hospital were analyzed retrospectively using hospital records between 2006-2012. Results: The median overall survival was 19.3 +/- 3.9 months for all patients. The median disease free and overall survivals were 24.3 +/- 5.3 and 44.1 +/- 12.9 months in patients in which radical surgery was performed, but in those with with inoperable disease they were only 5.3 +/- 1.5 and 10.7 +/- 3.2 months, respectively. Conclusions: BTCs have a poor prognosis. Surgery with a microscopic negative margin is still the only curative treatment.Biliary tract cancercholangiocarcinomasurvivalgallbladderAmpulla vateriArticleWOS:000343723600010